Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fusion Antibodies Plc (GB:FAB)
LSE:FAB
Fusion Antibodies Plc (FAB) Share Price & Analysis
3 Followers
FAB Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range2.80p - 9.50p
Previous Close3.15p
Volume639.51K
Average Volume (3M)1.03M
Market Cap
£3.00M
Enterprise Value2.88M
Total Cash (Recent Filing)£195.00K
Total Debt (Recent Filing)£75.00K
Price to Earnings (P/E)―
Beta0.91
Next Earnings
Dec 04, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding59,453,714
10 Day Avg. Volume33,983
30 Day Avg. Volume1,031,541
Standard Deviation38.82
R-Squared0.03
Alpha6.55
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)2408.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Fusion Antibodies Plc News
PremiumCompany Announcements
Fusion Antibodies Chair Ups Stake
PremiumCompany Announcements
Fusion Antibodies Unveils Interactive Investor Hub
PremiumCompany Announcements
Fusion Antibodies Plc Reports Strong Q1 Performance
PremiumCompany Announcements
Fusion Antibodies Strikes New Therapeutic Project DealPremiumCompany Announcements
Fusion Antibodies Hosts Investor Presentation
PremiumCompany Announcements
Fusion Antibodies Plc Anticipates Growth Despite Revenue DipOptions Prices
Currently, No data available
---
Ownership Overview
9.12% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
90.88% Public Companies and
Individual Investors
FAB FAQ
What was Fusion Antibodies Plc’s price range in the past 12 months?
Fusion Antibodies Plc lowest share price was 2.80p and its highest was 9.50p in the past 12 months.
What is Fusion Antibodies Plc’s market cap?
Currently, no data Available
When is Fusion Antibodies Plc’s upcoming earnings report date?
Fusion Antibodies Plc’s upcoming earnings report date is Dec 04, 2023 which is 231 days ago.
How were Fusion Antibodies Plc’s earnings last quarter?
Fusion Antibodies Plc released its earnings results on Sep 29, 2023. The company reported -0.057p earnings per share for the quarter, missing the consensus estimate of -0.043p by -0.014p.
Is Fusion Antibodies Plc overvalued?
According to Wall Street analysts Fusion Antibodies Plc’s price is currently Overvalued.
Does Fusion Antibodies Plc pay dividends?
Fusion Antibodies Plc does not currently pay dividends.
What is Fusion Antibodies Plc’s EPS estimate?
Fusion Antibodies Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fusion Antibodies Plc have?
Fusion Antibodies Plc has 95,365,560 shares outstanding.
What happened to Fusion Antibodies Plc’s price movement after its last earnings report?
Fusion Antibodies Plc reported an EPS of -0.057p in its last earnings report, missing expectations of -0.043p. Following the earnings report the stock price went down -22.619%.
Which hedge fund is a major shareholder of Fusion Antibodies Plc?
Currently, no hedge funds are holding shares in GB:FAB
---
Fusion Antibodies Plc Stock Smart Score
Company Description
Fusion Antibodies Plc
Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression.
---
Technical Analysis
---